Fortress Biotech, Inc. (FBIO)

2.72 +0.01 (+0.37%) USD  |  NASDAQ  |  Sep 04, 16:00
2.67 -0.05 (-1.84%) Pre-Market: 20:00
More

Fortress Biotech SG&A Expense (TTM) : 68.84M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for FBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 68.84M
March 31, 2026 86.80M
December 31, 2025 96.56M
September 30, 2025 108.70M
June 30, 2025 113.28M
March 31, 2025 95.34M
December 31, 2024 87.62M
September 30, 2024 83.37M
June 30, 2024 83.11M
March 31, 2024 86.72M
December 31, 2023 94.12M
September 30, 2023 99.71M
June 30, 2023 108.12M
March 31, 2023 112.73M
December 31, 2022 113.66M
September 30, 2022 113.16M
June 30, 2022 105.24M
March 31, 2022 95.57M
December 31, 2021 86.84M
September 30, 2021 74.95M
June 30, 2021 68.12M
March 31, 2021 63.19M
December 31, 2020 61.17M
September 30, 2020 59.69M
June 30, 2020 58.64M
Date Value
March 31, 2020 57.63M
December 31, 2019 55.59M
September 30, 2019 53.44M
June 30, 2019 52.16M
March 31, 2019 52.27M
September 30, 2018 54.69M
June 30, 2018 61.22M
March 31, 2018 61.77M
December 31, 2017 59.70M
September 30, 2017 52.71M
June 30, 2017 42.86M
March 31, 2017 37.88M
December 31, 2016 34.34M
September 30, 2016 32.64M
June 30, 2016 30.90M
March 31, 2016 26.07M
December 31, 2015 21.63M
September 30, 2015 17.62M
June 30, 2015 13.22M
March 31, 2015 11.81M
December 31, 2014 10.41M
September 30, 2014 10.19M
June 30, 2014 9.596M
March 31, 2014 9.709M
December 31, 2013 10.10M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Inovio Pharmaceuticals, Inc. 30.77M
Ironwood Pharmaceuticals, Inc. 64.55M
Kura Oncology, Inc. 135.28M
Spero Therapeutics, Inc. 19.85M
Cue Biopharma, Inc. 59.11M